Here are eight highlights:
1. The market will likely grow at a compound annual growth rate of 4.9 percent between 2013 and 2019.
2. In 2012, the market worth was $29.2 billion.
3. A growing geriatric population and increasing demand for noninvasive treatments are boosting the market.
4. The knee segment led the market in 2012, but may witness decline due to product recalls.
5. The hip segment is growing at a CAGR of 5.9 percent, due to an increased number of hip fractures.
6. North America led the market in 2012 because of the prevalence of obesity and osteoarthritis.
7. The Asia Pacific market will see significant growth due to an increasing population density and healthcare expenditure.
8. Key market players include NuVasive, Orthofix, Arthrex, Zimmer Biomet, Medtronic, Small Bone Innovations, TriMed, Conmed, Globus Medical, DePuy Synthes, Solana Surgical, Smith & Nephew, ArthroCare, Stryker, Integra LifeSciences, Aesculap, Vilex, aap Implantate and Wright Medical Technology.
More articles on devices:
Zimmer Biomet to present clinical data on Aspen MIS Fusion System & Timberline Systems at CNS meeting: 5 highlights
AxioMed receives Australian market approval for Freedom Viscoelastic Disc Replacement technology: 5 points
The Center for Musculoskeletal Disorders is 1st in Northeast to install Renaissance system in ambulatory outpatient setting: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
